C4 THERAPEUTICS INC's ticker is CCCC and the CUSIP is 12529R107. A total of 120 filers reported holding C4 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.07 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $2,041,217 | -61.6% | 345,969 | -43.0% | 0.03% | -63.0% |
| Q3 2022 | $5,321,000 | +18.1% | 606,721 | +1.6% | 0.08% | +11.0% |
| Q2 2022 | $4,504,000 | -47.5% | 597,374 | +68.8% | 0.07% | -30.5% |
| Q1 2022 | $8,586,000 | -26.1% | 353,912 | -1.9% | 0.10% | -11.8% |
| Q4 2021 | $11,615,000 | -59.5% | 360,710 | -43.8% | 0.12% | -65.0% |
| Q3 2021 | $28,658,000 | +264.8% | 641,399 | +209.0% | 0.34% | +226.9% |
| Q2 2021 | $7,855,000 | – | 207,583 | – | 0.10% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| COMMODORE CAPITAL LP | 481,094 | $15,939,000 | 8.67% |
| Bain Capital Life Sciences Investors, LLC | 1,642,209 | $54,406,000 | 3.42% |
| Darwin Global Management, Ltd. | 228,595 | $7,573,000 | 2.11% |
| Asymmetry Capital Management, L.P. | 139,343 | $4,616,000 | 2.10% |
| Cormorant Asset Management, LP | 2,490,065 | $80,021,000 | 1.90% |
| Logos Global Management LP | 477,928 | $15,834,000 | 1.36% |
| SPHERA FUNDS MANAGEMENT LTD. | 443,824 | $14,601,000 | 1.30% |
| Soleus Capital Management, L.P. | 268,548 | $8,897,000 | 1.17% |
| P.A.W. CAPITAL CORP | 40,000 | $1,325,000 | 1.17% |
| RTW INVESTMENTS, LP | 2,149,228 | $68,679,000 | 1.15% |